Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuwellis (NUWE) Capital Leases (2020 - 2022)

Nuwellis posted quarterly Capital Leases of $15000.0 for Q2 2022, down 63.41% year-on-year from $41000.0 in Q2 2021, and down 31.82% on a QoQ basis from $22000.0 in Q1 2022.

Nuwellis (NUWE) has 3 years of Capital Leases data on file, last reported at $15000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Capital Leases fell 63.41% year-over-year to $15000.0; the trailing twelve-month figure through Jun 2022 stood at $15000.0 (down 63.41% YoY), and the FY2021 full-year result was $28000.0, down 48.15% from the prior year.
  • Capital Leases for Q2 2022 stood at $15000.0, down from $22000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $60000.0 in Q3 2020 and bottomed at $15000.0 in Q2 2022.
  • The 3-year median for Capital Leases is $41000.0 (2021), against an average of $38555.6.
  • The widest annual swing landed in 2021, when Capital Leases fell 10.87%; it then tumbled 63.41% in 2022.
  • A 3-year view of Capital Leases shows it stood at $54000.0 in 2020, then sank by 48.15% to $28000.0 in 2021, then sank by 46.43% to $15000.0 in 2022.
  • The last three Capital Leases figures came in at $15000.0 (Q2 2022), $22000.0 (Q1 2022), and $28000.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 15,000.00
Mar 31, 2022 22,000.00
Dec 31, 2021 28,000.00
Sep 30, 2021 33,000.00
Jun 30, 2021 41,000.00
Mar 31, 2021 48,000.00
Dec 31, 2020 54,000.00
Sep 30, 2020 60,000.00
Jun 30, 2020 46,000.00